NCT00217178View on ClinicalTrials.gov

Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)

PHASE4UnknownINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

October 31, 2005

Conditions
AtherosclerosisCardiovascular Disease
Interventions
DRUG

Vitamins: Folic acid, B6, B12

Trial Locations (1)

L8L 2X2

Hamilton Health Sciences Corp., Hamilton

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Population Health Research Institute

OTHER

lead

Hamilton Health Sciences Corporation

OTHER